U.S. Professional Services Stock News

Key Insights The projected fair value for DXP Enterprises is US$171 based on 2 Stage Free Cash Flow to Equity DXP...

LightPath Technologies, Inc. ( NASDAQ:LPTH ) shares have had a really impressive month, gaining 37% after a shaky...

Key Insights RB Global's estimated fair value is US$184 based on 2 Stage Free Cash Flow to Equity RB Global's US$106...

When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is...

United Airlines Holdings, Inc. ( NASDAQ:UAL ) shareholders would be excited to see that the share price has had a great...

Terex Corporation ( NYSE:TEX ) shares have had a really impressive month, gaining 26% after a shaky period beforehand...

With a price-to-earnings (or "P/E") ratio of 21.2x Reliance, Inc. ( NYSE:RS ) may be sending bearish signals at the...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

The Royal Gold, Inc. ( NASDAQ:RGLD ) share price has done very well over the last month, posting an excellent gain of...

American Airlines Group Inc. ( NASDAQ:AAL ) shares have continued their recent momentum with a 26% gain in the last...

It hasn't been the best quarter for Hovnanian Enterprises, Inc. ( NYSE:HOV ) shareholders, since the share price has...

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

TETRA Technologies, Inc. ( NYSE:TTI ) shares have continued their recent momentum with a 26% gain in the last month...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...

Onto Innovation Inc. ( NYSE:ONTO ) shareholders would be excited to see that the share price has had a great month...

The fact that multiple Build-A-Bear Workshop, Inc. ( NYSE:BBW ) insiders offloaded a considerable amount of shares over...

BBB Foods (NYSE:TBBB) just posted quarterly results that turned heads, with sales jumping 37% and EBITDA margins near the top of expectations, supported by rapid store expansion and standout same store growth. See our latest analysis for BBB Foods. The strong quarter seems to be feeding into the narrative, with a 90 day share price return of 35.68 percent and year to date share price gains of 18.34 percent. This suggests momentum is clearly building off these growth signals. If this kind of...

Codere Online Luxembourg (NasdaqCM:CDRO) has reported its H1 2025 results with total revenue of about €203.9 million over the trailing twelve months and basic EPS of €0.02, supported by net income of just over €1.0 million. The company has seen revenue move from €189.1 million to €203.9 million on a trailing twelve month basis, while EPS has shifted from a loss of €0.05 to a modest profit of €0.02. This highlights how small changes in profitability can meaningfully affect margins in this kind...

Wondering if Customers Bancorp is still worth buying after its big run, or if most of the upside is already priced in? You are not alone. The stock has climbed 4.9% over the last week, 16.9% in the past month, and is now up an impressive 62.5% year to date, building on multi year gains of 60.5% over 1 year, 172.9% over 3 years, and 323.9% over 5 years. These moves have come alongside a shift in market sentiment toward regional banks, as investors have grown more comfortable with funding and...

Avadel Pharmaceuticals has completed patient enrollment in REVITALYZ, its Phase 3 trial testing once-at-bedtime LUMRYZ for idiopathic hypersomnia, advancing the drug beyond its existing US FDA-approved use in narcolepsy. This milestone, paired with LUMRYZ’s Orphan Drug Designation in idiopathic hypersomnia, could meaningfully influence expectations for the drug’s long-term role in sleep medicine. We’ll now explore how completion of REVITALYZ enrollment, and the prospect of label expansion...

Cintas Corporation ( NASDAQ:CTAS ) came out with its second-quarter results last week, and we wanted to see how the...

Innoviva, Inc. recently received US FDA approval for NUZOLVENCE (zoliflodacin), a first-in-class, single-dose oral antibiotic to treat uncomplicated urogenital gonorrhea in adults and pediatric patients. This marks one of the first new FDA-approved treatments for gonorrhea in nearly twenty years, underscoring Innoviva’s role in addressing antibiotic resistance and unmet infectious disease needs. We’ll now explore how bringing a first-in-class, single-dose oral treatment for gonorrhea affects...

Scholastic Corporation ( NASDAQ:SCHL ) shareholders are probably feeling a little disappointed, since its shares fell...

Some lululemon athletica inc. ( NASDAQ:LULU ) shareholders may be a little concerned to see that the President of...